This article was originally published in The Gray Sheet
Expansion of European headquarters based in the Swiss state of Vaud is valued at $31 mil. and will more than double production capacity there, the company reports. The move will add 200 new local jobs, bringing the total to 560 by 2006
You may also be interested in...
Suspension of heartburn remedy ranitidine looming in the EU as the European Medicines Agency stands by its original decision.
Illumina announced on 21 September it will buy back Grail, which is planning to commercialize its multi-cancer early detection blood test Galleri in 2021. See what Illumina’s CEO Francis deSouza said about it here.
Yes, Gottlieb’s in there twice; things get complicated when an agency starts to lose credibility.